Navigation Links
Odyssey Thera, Inc. Announces New Equity Financing and Initiation of Research Contract with Merck
Date:2/14/2013

SAN RAMON, Calif., Feb. 14, 2013 /PRNewswire/ -- Odyssey Thera, Inc., a privately held biotechnology company, announced today a new equity financing and the initiation of a research service contract with Merck, known as MSD outside the U.S. and Canada.

Additional participants in this financing include HBM Partners, Burrill & Company, and Lonza.  The financing, comprising new funds and debt conversion, totals $2.8M. These funds will be used to support continued advancement and expanded commercialization of Odyssey Thera's technologies and products.

"The support from current and new investors will expedite commercialization of Odyssey Thera technologies," said Dr. John K. Westwick , President and CEO of Odyssey Thera. "We look forward to supporting Merck and other leading discovery and development programs with these validated capabilities."   

About Odyssey Thera, Inc.

Odyssey Thera was founded over ten years ago with the goal of transforming drug discovery through deep cellular analysis. Odyssey's patented technologies measure disease-relevant pathway activity within living human cells. Unprecedented throughput and breadth of high-content assays enables assessment of key signaling nodes as well as the cellular system, allowing for rapid identification of drug candidates with optimal efficacy and safety profiles. The Company's leadership position in fundamental patents, technology, and know-how relating to cellular analysis has led to alliances with Pfizer, Abbott, Merck, the U.S. EPA, and others. To learn more about Odyssey Thera, please visit www.odysseythera.com.


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. HKTU Announces Development of a New Male Enhancement Supplement
2. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
3. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
4. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
5. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
6. CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
7. Xenon Announces Appointment of EVP, Research & Development
8. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
9. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
10. OrbusNeich Announces Favorable Ruling From the European Patent Office
11. Trovagene Announces Commercial Launch Timelines for HPV Carrier and Oncogene Mutation Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 2017 AVACEN Medical , Inc. (AVACEN) announced ... 2017 New Product Innovation Award for Its fibromyalgia pain ... secondary medical device market research by Frost & Sullivan,s industry ... drug-free pain relief product, the AVACEN 100, offers a safe ... widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... one of the most popular and least understood books in the Holy Scriptures, Revelation. ... descriptions that have baffled scholars for centuries. Many have tossed it off as mere ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
Breaking Medicine News(10 mins):